1.

Record Nr.

UNINA9910864197203321

Autore

Kattoor Jayasree

Titolo

Bone Tumors : Evidence-Based Approach in Diagnosis and Management

Pubbl/distr/stampa

Singapore : , : Springer, , 2024

©2024

ISBN

981-9947-38-3

Edizione

[1st ed.]

Descrizione fisica

1 online resource (364 pages)

Altri autori (Persone)

Nair PSindhu

GeotheJayasree

Disciplina

616.99471

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di contenuto

Intro -- Foreword -- Preface -- Acknowledgements -- Contents -- Abbreviations -- 1: Human Skeletal System -- 1.1  Bone Development -- 1.1.1  Intramembranous Ossification -- 1.1.2  Endochondral Ossification -- 1.2  Bone Growth -- 1.3  Classification of Bones -- 1.3.1  Long Bones -- 1.3.2  Short Bones -- 1.3.3  Flat Bones -- 1.3.4  Irregular Bones -- 1.4  Divisions of the Skeleton -- 1.5  Joints -- 1.6  Anatomy of Bones -- 1.6.1 Types of Bones -- 1.6.2  Bone Marrow -- 1.6.3  Periosteum -- 1.6.4  Bone Matrix -- 1.6.5  Cells of Bone -- 1.6.6  Microscopy of Bone -- 1.6.6.1  Lamellar Bone -- 1.6.6.2  Woven Bone -- 1.7  Cartilage -- 1.7.1  Types of Cartilage -- 1.7.2  Cartilage Cells -- References -- 2: Approach to Bone Tumours and Tumour-Like Lesions -- 2.1  Introduction -- 2.2  Evaluation of the Patient (Table 2.1) -- 2.2.1  History -- 2.2.2  Physical Examination -- 2.2.3  Imaging Modalities -- 2.2.4  Plain Radiograph -- 2.2.4.1  Location of Tumour/Lesion in the Bone -- 2.2.4.2  Pattern of Bone Destruction -- 2.2.4.3  Borders and Extent of the Lesion: Zone of Transition (ZOT) -- 2.2.4.4  Periosteal Reaction -- 2.2.4.5  Type of Matrix -- 2.2.4.6  Mono-Ostotic or Polyostotic -- 2.3  Laboratory Findings and Handling of Specimens -- 2.3.1  Bone Tumour Specimens -- 2.3.2  General Handling of Bone Tumour Specimens Before Dissection -- 2.3.3  Decalcification -- 2.3.4  Stains -- 2.3.5  Frozen Section -- 2.3.6  Handling of Biopsy and Curettage Specimen -- 2.3.7  Handling



of Amputation and Segmental Resection Specimen -- 2.3.8  Grading of Bone Sarcomas -- 2.4  Ancillary Investigations -- 2.4.1  Immunohistochemistry -- 2.4.2  Molecular Genetic Analysis -- 2.4.3  Other Ancillary Investigations -- References -- 3: Primary Bone Tumours -- 3.1  Syndromes Associated with Bone Tumours -- 3.2  Classification -- 3.3  Staging -- References -- 4: Cartilage Tumours.

4.1  Benign Cartilage Tumours -- 4.1.1  Subungual Exostoses -- 4.1.1.1 Clinical -- 4.1.1.2 Radiology -- 4.1.1.3 Microscopy -- 4.1.1.4 Differential diagnosis -- 4.1.1.5 Molecular -- 4.1.1.6 Treatment and prognosis -- 4.1.2  Bizarre Parosteal Osteochondromatous Proliferation (BPOP or Nora Lesion) -- 4.1.2.1 Clinical -- 4.1.2.2 Radiology -- 4.1.2.3 Pathology -- 4.1.2.4 DD -- 4.1.2.5 Molecular -- 4.1.2.6 Treatment and Prognosis -- 4.1.3  Enchondroma and Periosteal Chondroma -- 4.1.3.1 Clinical -- 4.1.3.2 Radiology -- 4.1.3.3  Pathology -- 4.1.3.4  Differential Diagnosis -- 4.1.3.5  Treatment and Prognosis -- 4.1.4  Enchondroma Protuberans -- 4.1.4.1 Radiology -- 4.1.4.2 DD -- 4.1.5  Enchondromatosis (Multiple Chondromas) -- 4.1.6  Osteochondromas (OC) [43-60] -- 4.1.6.1 Clinical -- 4.1.6.2 Radiological features -- 4.1.6.3  Pathology -- 4.1.6.4  Differential Diagnosis -- 4.1.6.5  Molecular -- 4.1.6.6 Treatment and prognosis -- 4.1.7  Osteochondromatosis (Multiple Hereditary Exostoses) -- 4.1.8  Chondroblastoma (CB) -- 4.1.8.1 Clinical -- 4.1.8.2 Radiological features -- 4.1.8.3 Pathology -- 4.1.8.4  Differential Diagnosis -- 4.1.8.5  Cytogenetics and Molecular Diagnostic Pathology -- 4.1.8.6  Treatment and Prognosis -- 4.1.9  Chondromyxoid Fibroma (CMF) -- 4.1.9.1 Clinical -- 4.1.9.2 Radiological Features -- 4.1.9.3 Pathology -- 4.1.9.4  Differential Diagnosis -- 4.1.9.5 Molecular -- 4.1.9.6 Treatment and Prognosis -- 4.1.10  Osteochondromyxoma (OMX) -- 4.1.10.1 Clinical -- 4.1.10.2 Radiology -- 4.1.10.3 Pathology -- 4.1.10.4 IHC -- 4.1.10.5 Molecular -- 4.1.10.6 Treatment and Prognosis -- 4.2  Intermediate (Locally Aggressive) Tumours -- 4.2.1 Synovial Chondromatosis -- 4.2.2  Atypical cartilaginous tumour/grade I chondrosarcoma (ACT/CS 1) -- 4.2.2.1 Radiology -- 4.2.2.2 Pathology -- 4.2.2.3 Treatment and Prognosis -- 4.3  Malignant.

4.3.1  Chondrosarcoma (CS) -- 4.3.1.1  Conventional CS -- Clinical -- Radiology -- Pathogenesis -- Pathology -- Grading in CS -- DD -- Treatment and Prognosis -- 4.3.2  Variants of Chondrosarcoma -- 4.3.2.1  Periosteal Chondrosarcoma -- 4.3.2.2  Clear Cell Chondrosarcoma (CCCS) -- Clinical -- Radiology -- Pathology -- Differential diagnosis -- Treatment and prognosis -- 4.3.2.3  Mesenchymal CS -- Clinical -- Radiology -- Microscopy -- IHC -- Molecular -- DD -- Treatment and prognosis -- 4.3.2.4  Dedifferentiated CS (DDCS) -- Clinical -- Radiology -- Pathogenesis -- Both conventional and dedifferentiated CS show identical TP53 and IDH mutations [124, 127]. Pathology -- DD -- Treatment and prognosis -- 4.3.3  Myxoid CS of Bone (MCS) -- 4.3.3.1 Clinical -- 4.3.3.2 Radiology -- 4.3.3.3 Pathology -- 4.3.3.4 IHC -- 4.3.3.5 DD -- 4.3.3.6 Treatment and prognosis -- 4.4  Other Chondroid Lesions Mistaken for Neoplasm -- 4.4.1  Exuberant Callus -- 4.4.2  Intervertebral Disc -- References -- Subungual Exostosis -- BPOP -- Enchondroma and Enchondromatosis -- Osteochondroma and Osteochondromatosis -- Chondroblastoma -- Chondromyxoid Fibroma -- Chondrosarcoma -- Periosteal Chondrosarcoma -- Dedifferentiated Chondrosarcoma -- Mesenchymal Chondrosarcoma -- Clear Cell Chondrosarcoma -- Myxoid Chondrosarcoma -- Osteochondromyxoma -- Exuberrant Callus -- Costochondral Junction -- Intervertebral Disc -- 5: Osteogenic Tumours -- 5.1  Terminology -- 5.2  Benign



and Intermediate Osteoid-Producing Tumours -- 5.2.1  Osteoma -- 5.2.1.1  Clinical -- 5.2.1.2  Radiology -- 5.2.1.3  Pathology -- 5.2.1.4  Treatment -- 5.2.2  Osteoid Osteoma (OO) -- 5.2.2.1  Clinical -- 5.2.2.2  Radiology -- 5.2.2.3  Pathology -- 5.2.2.4  Molecular Findings -- 5.2.2.5  Treatment and Prognosis -- 5.2.3  Osteoblastoma (OB) -- 5.2.3.1  Clinical -- 5.2.3.2  Radiology -- 5.2.3.3  Pathology.

5.2.3.4  IHC -- 5.2.3.5  Molecular -- 5.2.3.6  DD -- 5.2.3.7  Treatment and Prognosis -- 5.3  Malignant tumours-Osteosarcoma -- 5.3.1  Clinical -- 5.3.2  Radiology -- 5.3.3  Pathology -- 5.3.4  Immunohistochemistry -- 5.3.5  Molecular -- 5.3.6  Grading of Osteosarcoma -- 5.3.7  Morphological Subtypes -- 5.3.7.1  Low-Grade Central Osteosarcoma (LGCOS) -- Clinical -- Radiology -- Pathology -- IHC -- Molecular -- DD -- Treatment and Prognosis -- 5.3.7.2  Conventional Osteosarcoma (COS) -- 5.3.7.3  Telangiectatic Osteosarcoma (TAEOS) -- Radiology -- Pathology -- 5.3.7.4  Small Cell Osteosarcoma (SCOS) -- 5.3.7.5  Other Unusual Morphological Variants -- Giant Cell-Rich OS -- Differential Diagnosis -- Epithelioid OS -- Osteoblastoma-Like OS -- Chondromyxoid Fibroma-Like OS -- Chondroblastoma-Like OS -- Clear Cell OS -- MFH-Like OS -- 5.3.8  Surface Osteosarcomas -- 5.3.8.1  Parosteal OS -- Radiology -- Pathology -- IHC -- Molecular -- Differential Diagnosis -- Treatment -- 5.3.8.2  Periosteal Osteosarcoma -- Radiology -- Pathology -- DD -- Molecular -- Treatment and Prognosis -- 5.3.8.3  High-Grade Surface Osteosarcom -- Pathology -- Treatment and Prognosis -- 5.3.9  Osteosarcoma of Jaw -- 5.3.10  Secondary Osteosarcoma -- 5.3.11  Composite Sarcoma of Bone -- 5.3.12  Multicentric Osteosarcoma -- 5.3.13  Mimickers of Osteosarcoma -- 5.3.14  Osteosarcomatous Areas in Other Tumours -- 5.3.15  Treatment and Prognosis of Osteosarcoma -- 5.3.15.1  Assessment of the Effect of Chemotherapy -- 5.3.15.2  Prognosis -- 5.3.16  Cytogenetic [150] and Molecular [103, 124]findings in OS (Table 5.14) -- 5.4  Other Osteoid-Producing Lesions Mimicking Tumour -- 5.4.1  Heterotopic Ossification (Myositis Ossificans) -- 5.4.1.1  Clinical -- 5.4.1.2  Radiology -- 5.4.1.3  Pathology -- 5.4.1.4  Treatment and prognosis -- 5.4.2  Bone Island -- 5.4.2.1  Radiology.

5.4.2.2  Pathology -- 5.4.2.3  DD -- 5.4.3  For stress Fracture, Insufficiency Fracture and Avulsion Injury, see Chap. 17. -- References -- Osteoma, Osteoid Osteoma, Osteoblastoma -- Osteosarcoma -- Low Grade Central OS -- Small Cell Osteosarcoma -- Parosteal -- Periosteal OS -- High Grade Surface OS -- Secondary OS -- Composite Sarcoma of Bone -- Myositis Ossificans -- Bone Island -- 6: Fibrous Tumours and Lesions of Bone -- 6.1  Fibrogenic Tumours: Classification [59, 62] -- 6.2  Desmoplastic Fibroma -- 6.2.1 Radiology -- 6.2.2 Pathology -- 6.2.3 Treatment and Prognosis -- 6.3  Other Benign Fibrous Tumours of Bone -- 6.3.1  Fibrous Dysplasia (FD) -- 6.3.1.1 Clinical -- 6.3.1.2 Radiology -- 6.3.1.3 Pathology -- 6.3.1.4 Differential diagnosis -- 6.3.1.5 Molecular -- 6.3.1.6 Treatment and Prognosis -- 6.3.1.7  Malignancy in Fibrous Dysplasia -- 6.3.2  Osteofibrous Dysplasia (OFD) -- 6.3.2.1 Clinical -- 6.3.2.2 Radiology -- 6.3.2.3 Pathology -- 6.3.3  Periosteal Desmoid -- 6.3.4  Fibrocartilaginous Mesenchymoma -- 6.3.5  Myofibroma (Infantile Myofibromatosis) -- 6.4  Malignant Tumours -- 6.4.1  Fibrosarcoma (FS) -- 6.4.1.1 Clinical -- 6.4.1.2 Radiology -- 6.4.1.3 Pathology -- 6.4.1.4 DD -- 6.4.1.5  Treatment and Prognosis -- 6.4.2  Sclerosing Epithelioid Fibrosarcoma of Bone -- 6.4.2.1 Clinical -- 6.4.2.2 Radiology -- 6.4.2.3 Pathology -- 6.4.2.4 IHC and Molecular -- 6.4.2.5 Treatment and Prognosis -- 6.5  Fibrohistiocytic Tumours -- 6.5.1  Malignant -- 6.5.1.1  Undifferentiated Pleomorphic Sarcoma (UPS) --



Clinical -- Radiology -- Pathology -- DD -- Treatment and Prognosis -- References -- Desmoplastic Fibroma -- Fibrous Dysplasia -- Osteo Fibrous Dysplasia -- Myofibroma -- Fibrosarcoma and Undifferentiated Sarcoma -- 7: Giant Cell-Rich Tumours -- 7.1  Classification of Osteoclastic Giant Cell-Rich tumours [60] -- 7.2  Aneurysmal Bone Cyst (ABC).

7.2.1 Clinical.